GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » PS Ratio

AIM Vaccine Co (HKSE:06660) PS Ratio : 6.88 (As of May. 28, 2024)


View and export this data going back to 2022. Start your Free Trial

What is AIM Vaccine Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, AIM Vaccine Co's share price is HK$7.38. AIM Vaccine Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.07. Hence, AIM Vaccine Co's PS Ratio for today is 6.88.

The historical rank and industry rank for AIM Vaccine Co's PS Ratio or its related term are showing as below:

HKSE:06660' s PS Ratio Range Over the Past 10 Years
Min: 5.72   Med: 15.41   Max: 45.83
Current: 6.88

During the past 5 years, AIM Vaccine Co's highest PS Ratio was 45.83. The lowest was 5.72. And the median was 15.41.

HKSE:06660's PS Ratio is ranked better than
58.2% of 1000 companies
in the Biotechnology industry
Industry Median: 9.055 vs HKSE:06660: 6.88

AIM Vaccine Co's Revenue per Sharefor the six months ended in Dec. 2023 was HK$0.58. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.07.

Warning Sign:

AIM Vaccine Co Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of AIM Vaccine Co was -8.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -12.60% per year.

During the past 5 years, AIM Vaccine Co's highest 3-Year average Revenue per Share Growth Rate was 10.30% per year. The lowest was -12.60% per year. And the median was -1.15% per year.

Back to Basics: PS Ratio


AIM Vaccine Co PS Ratio Historical Data

The historical data trend for AIM Vaccine Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AIM Vaccine Co PS Ratio Chart

AIM Vaccine Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
- - - 20.27 7.32

AIM Vaccine Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
PS Ratio Get a 7-Day Free Trial - - 20.27 - 7.32

Competitive Comparison of AIM Vaccine Co's PS Ratio

For the Biotechnology subindustry, AIM Vaccine Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AIM Vaccine Co's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AIM Vaccine Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where AIM Vaccine Co's PS Ratio falls into.



AIM Vaccine Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

AIM Vaccine Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=7.38/1.072
=6.88

AIM Vaccine Co's Share Price of today is HK$7.38.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


AIM Vaccine Co  (HKSE:06660) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


AIM Vaccine Co PS Ratio Related Terms

Thank you for viewing the detailed overview of AIM Vaccine Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AIM Vaccine Co (HKSE:06660) Business Description

Traded in Other Exchanges
N/A
Address
91 Jianguo Road, 25th Floor, Building A, Chaoyang, Beijing, CHN
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development, manufacturing and commercialization. The products available for sale mainly include Recombinant HBV vaccine, Human rabies vaccine, HFRS Vaccine, hepatitis A vaccine (human diploid cell), Group A, C, Y and W135 MPSV, mumps vaccine, freeze-dried human rabies vaccine (Vero cell) and ACYW135 meningococcal polysaccharide vaccine. Geographically, the company generates all of its revenues in the PRC.
Executives
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Shang Yin Xing Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Shi Bei Lun Qu Guo You Zi Ben Yun Ying You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Kong Gu You Xian Gong Si 2101 Beneficial owner
Yong Zhou Qing Teng Mao Yi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Lihua 2201 Interest of corporation controlled by you
Shang Hai Xun Jing Qi Ye Guan Li Zhong Xin You Xian He Huo 2201 Interest of corporation controlled by you
Zhu Hai Tong Dao Ming Tian Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Mei Hua Sheng Wu Ke Ji Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
La Sa Mei Hua Sheng Wu Tou Zi Kong Gu You Xian Gong Si 2101 Beneficial owner
Xi Zang Dong Fang Zhi Hui Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Shen Yang Qian Qian Qi Ye Guan Li Zi Xun You Xian Gong Si 2101 Beneficial owner

AIM Vaccine Co (HKSE:06660) Headlines

No Headlines